Prof. Giovanni Camussi M.D.

University of Turin
Department of Medical Sciences, Molecular Biotechnology Center

Since 1998 is Prof. Camussi full professor in the Department of Internal Medicine, Chairman of Nephrology, Faculty of Medicine and School of Biotechnology, University of Turin/IT. Currently, he is interested in the role of bone-marrow derived or resident stem cells in renal tissue regeneration as well as in the molecular mechanisms driving stem cell recruitment and differentiation. Moreover, he is working on the pathogenesis of diabetic nephropathy.

Please click here to view the curriculum vitae (PDF) and a list of publications

Prof. Luc Douay

University Pierre et Marie Curie and Saint Antoine/Trousseau Hospital

Luc Douay is Director of the Biological Hematology Laboratory. He was Scientific & Medical Director of the French Blood Agency and expert at the French Biomedicine Agency. He is Scientific Director for the Cell Therapy Center in Paris and director of the INSERM Research Unit S938 dedicated to the proliferation and differentiation of stem cells. His research team is composed of more than 35 MDs, PhDs, engineers and technicians located in the Research Centre St Antoine (Paris).

Prof. Luc Douay is a pioneer in the stem cell research and internationally known for his expertise in ex vivo expansion of stem cells in view of Hematopoietic Stem Cell transplantation and Red Blood Cell Production for transfusion purpose.

© Cellprothera

To view the list of publications please click here.

Koji Eto M.D. Ph.D.   

Kyoto University    
Center for iPS Cell Research and Application (CiRA)

Willy A. Flegel, MD

NIH Clinical Center
Chief, Laboratory Services Section
Department of Transfusion Medicine

Dr. Flegel came to the NIH Clinical Center Department of Transfusion Medicine (DTM) in 2009 as Chief, Laboratory Services Section. In this role, he directs the Transfusion Services (TSL) and HLA Laboratories. During his tenure, the TSL expanded genotyping for RBC antigens and the HLA Laboratory established KIR gene expression assays. Research interests include blood group genotyping; relationship of genotype, phenotype and function of blood group proteins; stem cell surface antigens in vivo and during ex vivo expansion; and immunogenetics in hematopoietic stem cell transplantation. In the year 2004 he gets the Philip Levine Award of the German Society for Transfusion Medicine and Immunohematology.

For a curiculum vitae and a list of publications please click here.

Prof. Dr. Katharina Fleischhauer

University Hospital of Essen 
Director of the Institute for Cell Therapy Research 
Institute Group 1

Katharina Fleischhauer has studied medicine in Bonn. Afterwards she was working for four years at the Memorial Sloan Kettering Cancer Center in New York. There she became acquainted with the Immunology of the transplantation of external haematopoietic stem cells. From 1992 until 2013 she worked at the Instituto Scientifico San Raffaele in Mailand, the largest privat research institution in Italy. There she was at first active in the research as a Marie-Curie-Fellow in the tumor immunology, funded by the EU. Later she was director of a research group in hematology and Immunogenetics. At the same time she established the molecular-biological diagnostics laboratory for the stem cell donor selection, which she managed since 1998.
© Pressemitteilung der Universität Duisburg-Essen, Ulrike Bohnsack

Please click here to view the curriculum vitae and a list of publications

Prof. Dr. Wolfgang Hoffmann

University Medicine Greifswald 
Institute for Community Medicine 
Section Epidemiology of Health Care and Community Health

Since 2007 Prof. Dr. Wolfgang Hoffmann is acting director of the Institute for Community Medicine and since 2012 site speaker of the German Center for Neurodegenerative Diseases (DZNE) at the site Rostock/ Greifswald.

Here you can view the curriculum vitae

Prof. Dr. Volker Kiefel

University Medicine Rostock 
Director of the Institute for Transfusion Medicine

Since 1999 Dr. Volker Kiefel is director of the Institute for Transfusion Medicine at University Rostock. In 1991 he received the Fritz-Schiffner-Preis of the German Society for Transfusion Medicine and Immunohemathology for his scientifc research.

For a curiculum vitae and a list of publications please click here

Prof. Lorenzo Moretta

Istituto Giannina Gaslini

Prof. Lorenzo Moretta is the Scientific Director of the Istituto Giannina Gaslini, Genova and Professor of General Pathology and Pathophysiology, University of Genova, Italy.
Professor Moretta has been a Member of Academia Europaea since 2000, EMBO Member since 2003 and a Member of Accademia dei Lincei since 2009. He is currently President of the European Federation of Immunological Societies (EFIS). Over 43.000 citations, H-index=112. A fundamental contribution of the laboratory directed by Professor Moretta, in close collaboration with the laboratory directed by Professor Alessandro Moretta, Professor of Histology at the University of Genoa, is the definition of the mechanisms regulating natural killer (NK) cell function (tumor cell killing) thanks to the discovery of inhibiting receptors specific for human leukocyte antigen (HLA) class I molecules (named KIR) and of receptors responsible for NK cell activation and for induction of tumor cell killing processes. The genes coding for these receptors were cloned in the laboratory of Professor Moretta. Overall, 15 new receptor molecules were identified and cloned by the research group of Professor Moretta. 

Please find here the curriculum vitae and a list of publications.

Prof. Dr. med. Michael Müller-Steinhardt

Institute for Transfusion Medicine and Immunology Mannheim
Director of Department Donation, Production and Transplantation Immunology

Professor Müller-Steinhardt is Senior Physician at the Institute for Transfusion Medicine and Immunology Mannheim, DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH since 2008. He is engaged in the studies of the development of a multiplex PCR for IL-6 -597/-572/-174 genotyping, of the characterization of the IL-6 production for hemodialysis patients depending on IL-6 -597/-572/-174 genotype and the expansion and the technical development of the public cord blood bank in Mannheim. Professor Müller-Steinhardt is focusing on donor research and the impact of the demographic change on future blood product supply.

For his curriculum vitae and the publications please click here.

Dr. Ruth Offergeld

Robert Koch Institute

Dr. Ruth Offergeld is a specialist in transfusion medicine and an epidemiologist. Since 2002 Dr. Ruth Offergeld is working at the Robert Koch Institute in Germany and is currently the chair of the National Advisory Committee “Blood” (Arbeitskreis Blut). Her main activities and interests are the surveillance and management of infectious diseases among blood donors in Germany.

Click here to view the curriculum vitae

Prof. Dr. Johannes Oldenburg

University of Bonn 
Director of the Institute of Experimental Haematology and Transfusion Medicine.

Prof. Dr. Johannes Oldenburg is Profesor and Director of the Institute of Experimental Haematology and Transfusion Medicine in Bonn since 2005 and consultant and adviser for numerous scientific journals. For his key research ares Hemophilia A he received several awards.

Click here for curriculum vitae (PDF).

Prof. Martin Olsson

Lund University
Division of Hematology and Transfusion Medicine

Martin L. Olsson received his M.D. (1991) and Ph.D. (1997) from Lund University in Sweden where he is a Professor and Senior Consultant in Transfusion Medicine. He is the Medical Director of the Nordic Reference Laboratory for Genetic Blood Group Typing in Lund. He has been a Visiting Scientist at IBGRL/BITS in Bristol, UK (1996), and a Visiting Associate Professor/Lecturer at Harvard Medical School, Boston, MA, USA (2003-2008). His main clinical and research interest is the molecular genetics of red cell surface antigens with a special emphasis on carbohydrate histo-blood groups and DNA-based blood group typing but also host-pathogen interactions. In addition, his group studies mechanisms of protection against hemolysis, including bacterially-derived exoglycosidases to develop ABO-universal transfusions. Prof. Olsson has published 115 peer-reviewed original and review articles, and 240 peer-reviewed congress abstracts. He is a co-author of the new edition of the popular Blood Group Antigen FactsBook (2012) and serves as an Associate Editor of Transfusion Medicine (2006- ) and is also a member of the Editorial Board of Transfusion. His many awards include the Jean Julliard Prize from ISBT (2000), the Race & Sanger Award from BBTS (2004), the Fernström Young Scientist Prize (2004), the Hain Foundation Prize (2005), Margot Kruskall Lectureship by Harvard Medical School (2008), the Claes F. Högman Honorary Lectureship from the Swedish Society of Transfusion Medicine (2010), the Harold A. Kaminetzksy best non-US article Prize in Obstetrics & Gynecology (co-author, 2012) and the James Blundell Award by the BBTS (2013).

To view the list of publications please click here.

Dr. Effi Petersdorf

Seattle Cancer Care Alliance
Medical Oncology Division

Dr Petersdorf served as Chair of the US National Marrow Donor Program Histocompatibility Committee, Councillor of the American Society of Histocompatibility and Immunogenetics, and Board Member of the American Society for Blood and Marrow Transplantation. Dr. Petersdorf received the Presidential Early Career Award for Scientists and Engineers from President Clinton, and the Mechtild-Harf Prize of Deutsche Stiftung Leben Spenden.
Dr. Petersdorf's research is focused on human genetics in transplantation and cancer biology, in particular, genes within the major histocompatibility complex and immune response genes. She is Project Leader of the International Histocompatibility Working Group in Hematopoietic Cell Transplantation, a collaborative research consortium of transplant clinicians and immunogeneticists.

© Faculty of 1000 Ltd.

For a list of publications please click here.

Dr. Sentot Santoso

University Hospital Giessen and Marburg GmbH 
Institute for Clinical Immunology and Transfusion Medicine

With the production of monoclonal antibodies Dr. Santoso has created the foundations for the molecular characterization of blood group properties of platelets and white blood cells. The developed laboratory diagnostic techniques are now considered international gold standard for the determination of antigens and antibodies against blood cells. The significant efforts have contributed to a sustained improvement in the diagnosis and patient care. Recently, the research group of Dr. Santoso managed to discover new, previously unknown molecules on endothelial cells (JAM-C) and leukocytes (CD177) to decipher their role in inflammation and development of atherosclerosis. These discoveries open up new strategies for the treatment of cardiovascular diseases.
© Press release idw-Informationsdienst Wissenschaft e.V.

Dr. Ingrid Veldhuizen

Sanquin Blood Supply Foundation
Department of Donor Studies

Ingrid Veldhuizen currently works at the department Donor Studies within the Research division of Sanquin.

Here you can view the list of publications.

Univ.-Prof. Dr. Christian von Heymann

Charité-University Medicine Berlin 
Department of Anesthesiology and Operative Intensive Care Medicine 
Deputy Head of Department

Prof. Dr. Christian Heymann is working at Charité-Universitätsmedizin Berlin as Professor for Anesthesiology and Intensive Care Medicine. In 2006 he receive the poster award of the International Anesthesia Research Society, San Francisco for the research topic "Pronounced Hemodilution during Cardiopulmonary Bypass Does Not Affect Gut Permeability"

Please click here to view the curriculum vitae